Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk

被引:14
作者
Inzaule, Seth C. [1 ,2 ,3 ]
Weidle, Paul J. [4 ]
Yang, Chunfu [4 ]
Ndiege, Kenneth [1 ]
Hamers, Raph L. [2 ,3 ]
de Wit, Tobias F. Rinke [2 ,3 ]
Thomas, Timothy [4 ]
Zeh, Clement [5 ]
机构
[1] Kenya Govt Med Res Ctr, Kisumu, Kenya
[2] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[3] Amsterdam Inst Global Hlth & Dev Amsterdam, Amsterdam, Netherlands
[4] Ctr Dis Control & Prevent, Atlanta, GA USA
[5] Ctr Dis Control & Prevent, Kisumu, Kenya
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CHILD TRANSMISSION; REVERSE-TRANSCRIPTASE; ANTIRETROVIRAL THERAPY; HIV; SUBTYPE; INHIBITOR; PATTERNS; PREVENTION; IMPACT;
D O I
10.1093/jac/dkw039
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: K65R is a relatively rare drug resistance mutation (DRM) selected by the NRTIs tenofovir, didanosine, abacavir and stavudine and confers cross-resistance to all NRTIs except zidovudine. Selection by other NRTIs is uncommon. Objectives: In this study we investigated the frequency of emergence of the K65R mutation and factors associated with it in HIV-1-infected infants exposed to Low doses of maternal Lamivudine, zidovudine and either nevira pine or nelfinavir ingested through breast milk, using specimens collected from the Kisumu Breastfeeding Study. Methods: Plasma specimens with viral Load >= 1000 copies/mL collected from HIV-infected infants at 0-1, 2, 6, 14, 24 and 36 weeks of age and maternal samples at delivery were tested for HIV drug resistance using Sanger sequencing of the polymerase gene. Factors associated with K65R emergence were assessed using Fisher's exact test and the Wilcoxon rank-sum test. Results: K65R was detected in samples from 6 of the 24 infants (25%) who acquired HIV-1 infection by the age of 6 months. K65R emerged in half of the infants by 6 weeks and in the rest by 14 weeks of age. None of the mothers at delivery or the infants with a positive genotype at first time of positivity had the K65R mutation. Infants with K65R had Low baseline CD4 cell counts (P=0.014), were more Likely to have DRMs earlier (<= 6 weeks versus >= 14 weeks, P=0.007) and were more Likely to have multiclass drug resistance (P=0.035). M184V was the most common mutation associated with K65R emergence. K65R had reverted by 3 months after cessation of breastfeeding. Conclusions: A high rate of K65R emergence may suggest that ingesting Low doses of Lamivudine via breast milk could select for this mutation. The presence of this mutation may have a negative impact on future responses to NRTI-based ART. More in vitro studies are, however, needed to establish the molecular mechanism for this selection.
引用
收藏
页码:1619 / 1626
页数:8
相关论文
共 37 条
  • [1] [Anonymous], 2015, How AIDS changed everything - MDG6: 15 years, 15 lessons of hope from the AIDS response
  • [2] [Anonymous], 2011, World AIDS day report
  • [3] Children Who Acquire HIV Infection Perinatally Are at Higher Risk of Early Death than Those Acquiring Infection through Breastmilk: A Meta-Analysis
    Becquet, Renaud
    Marston, Milly
    Dabis, Francois
    Moulton, Lawrence H.
    Gray, Glenda
    Coovadia, Hoosen M.
    Essex, Max
    Ekouevi, Didier K.
    Jackson, Debra
    Coutsoudis, Anna
    Kilewo, Charles
    Leroy, Valeriane
    Wiktor, Stefan Z.
    Nduati, Ruth
    Msellati, Philippe
    Zaba, Basia
    Ghys, Peter D.
    Newell, Marie-Louise
    [J]. PLOS ONE, 2012, 7 (02):
  • [4] The impact of Prevention of Mother to Child Transmission (PMTCT) programmes on maternal health care in resource-poor settings: looking beyond the PMTCT programme-a systematic review
    Both, J. M. C.
    van Roosmalen, J.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 117 (12) : 1444 - 1450
  • [5] HIV-1 reverse transcriptase (RT) genotypic patterns and treatment characteristics associated with the K65R RT mutation
    Boucher, S.
    Recordon-Pinson, P.
    Ragnaud, J. M.
    Dupon, M.
    Fleury, H.
    Masquelier, B.
    [J]. HIV MEDICINE, 2006, 7 (05) : 294 - 298
  • [6] Brenner Bluma G., 2009, HIV Therapy, V3, P583, DOI 10.2217/HIV.09.40
  • [7] Brodard V, 2005, JAIDS-J ACQ IMM DEF, V39, P250
  • [8] Antiretroviral Resistance Patterns and HIV-1 Subtype in Mother-Infant Pairs after the Administration of Combination Short-Course Zidovudine plus Single-Dose Nevirapine for the Prevention of Mother-to-Child Transmission of HIV
    Chalermchockcharoenkit, Amphan
    Culnane, Mary
    Chotpitayasunondh, Tawee
    Vanprapa, Nirun
    Leelawiwat, Wanna
    Mock, Philip A.
    Asavapiriyanont, Suvanna
    Teeraratkul, Achara
    McConnell, Michelle S.
    McNicholl, Janet M.
    Tappero, Jordan W.
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 49 (02) : 299 - 305
  • [9] Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission
    Church, Jessica D.
    Omer, Saad B.
    Guay, Laura A.
    Huang, Wei
    Lidstrom, Jessica
    Musoke, Philippa
    Mmiro, Francis
    Jackson, J. Brooks
    Eshleman, Susan H.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (07) : 1075 - 1082
  • [10] (-)-2'-DEOXY-3'-THIACYTIDINE IS A POTENT, HIGHLY SELECTIVE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 REPLICATION INVITRO
    COATES, JAV
    CAMMACK, N
    JENKINSON, HJ
    JOWETT, AJ
    JOWETT, MI
    PEARSON, BA
    PENN, CR
    ROUSE, PL
    VINER, KC
    CAMERON, JM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) : 733 - 739